Alliancebernstein L.P. Aclaris Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$14.33 - $18.37 $204,919 - $262,691	14,300 Added 31.02%	60,400 $951,000
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $43,688 - $73,443	4,300 Added 10.29%	46,100 $644,000
Q1 2022 May 13, 2022	BUY	$9.74 - $17.92 $89,608 - $164,864	9,200 Added 28.22%	41,800 $721,000
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $58,896 - $88,751	4,800 Added 17.27%	32,600 $474,000
Q2 2021 Jul 30, 2021	BUY	$17.08 - $29.6 $474,823 - $822,880	27,800 New	27,800 $488,000
Q2 2020 Aug 13, 2020	SELL	$1.04 - $1.73 $57,408 - $95,496	-55,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $16,401 - $54,362	7,700 Added 16.21%	55,200 $121,000
Q1 2019 May 14, 2019	BUY	$5.63 - $7.84 $45,040 - $62,720	8,000 Added 20.25%	47,500 $285,000
Q4 2018 Feb 13, 2019	BUY	$6.3 - $15.4 $54,180 - $132,440	8,600 Added 27.83%	39,500 $292,000
Q3 2018 Nov 08, 2018	BUY	$14.38 - $20.89 $30,198 - $43,869	2,100 Added 7.29%	30,900 $449,000
Q2 2018 Aug 13, 2018	BUY	$16.46 - $20.33 $85,592 - $105,715	5,200 Added 22.03%	28,800 $575,000
Q1 2018 May 14, 2018	BUY	$17.08 - $25.64 $70,028 - $105,124	4,100 Added 21.03%	23,600 $413,000
Q3 2017 Nov 13, 2017	BUY	$23.02 - $28.8 $448,890 - $561,600	19,500	19,500 $503,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.